Supportive Care | Specialty

The OncLive Supportive Care condition center page is a comprehensive resource for clinical news and expert insights on supportive care and management of patients with cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, best practices, and ongoing research as it relates to supportive care for patients with cancer.

Dual Targeting of BRAF and MEK in NSCLC

August 27th 2015

CNS Activity With Next-Generation ALK Inhibitors

August 27th 2015

Overcoming EGFR Inhibitor Resistance in Non-T790M-Positive NSCLC

August 27th 2015

Impressive Findings for Next-Generation EGFR Inhibitors

August 27th 2015

Upfront EGFR-Targeted Therapy for NSCLC

August 27th 2015

FDA Expands Eltrombopag Indication for Pediatric Chronic ITP

August 24th 2015

The FDA has approved eltrombopag as a treatment for pediatric patients with chronic immune thrombocytopenic purpura following a lack of response to other therapies or splenectomy.

Palliative Care Issues in Gynecologic Cancer

August 17th 2015

Palliative care should address the unique symptom profile of gynecologic cancer and be tailored to individual socioeconomic environments.

Start Discussions About Palliative Care Upon Initial Metastatic Diagnosis

August 11th 2015

In the urologic oncology field, urologists can play an important role in successful comprehensive care by incorporating palliative care in their treatment regimens.

Telotristat Etiprate Cuts Carcinoid Syndrome-Related Diarrhea in Phase III Study

August 3rd 2015

Treatment with telotristat etiprate significantly reduced the average number of daily bowel movements compared with placebo for patients with carcinoid syndrome that was not adequately controlled with a somatostatin analog.

Remaining Challenges in CINV Treatment

August 3rd 2015

Future Directions in the Management of CINV

August 3rd 2015

Cost and Quality Considerations in CINV Management

August 3rd 2015

Guidelines for CINV Prophylaxis and Treatment

August 3rd 2015

Netupitant Plus Palonosetron for CINV Prevention

August 3rd 2015

Educating Patients About CINV

August 3rd 2015

Role of the Pharmacist in CINV Treatment

August 3rd 2015

Available Treatment Options for CINV

August 3rd 2015

Understanding the Types and Causes of CINV

August 3rd 2015

Importance of Proactive CINV Management

August 3rd 2015

Court Clears First US Biosimilar for Future Marketing

July 21st 2015

An appellate court ruled that the FDA-approved biosimilar Zarxio can be marketed in the United States after September 2, 2015.